Skip to content
1356-Next-Generation ADCs: Path Toward Precision Medicine episode artwork

Jul 30, 2026 25 min

1356-Next-Generation ADCs: Path Toward Precision Medicine

from Paper Talk

This collection of research excerpts explores the current landscape and future trajectory of antibody-drug conjugates (ADCs) in oncology. The sources highlight the critical evolution of precision medicine, emphasizing how next-generation therapies must address challenges like antigen heterogeneity and complex resistance mechanisms. By integrating multidimensional biomarkers and advanced imaging techniques, researchers aim to refine patient selection and improve the therapeutic window. The text also details the shift toward rational drug combinations and the development of bispecific ADCs to enhance efficacy while minimizing toxicities. Ultimately, these findings provide a comprehensive framework for advancing ADCs from late-stage salvage treatments to personalized early-intervention strategies. References: Pistilli B, Colombo R, Mosele M F, et al. Antibody-drug conjugates in precision oncology[J]. Cancer Cell, 2026, 44(6): 1126-1146. 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1356-Next-Generation ADCs: Path Toward Precision Medicine

0:00 25:39

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 25 minutes long.

When was this Paper Talk episode published?

This episode was published on July 30, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.